• Latest Posts

Netherlands Cancer Institute to use Proscia platform

Vésale Bioscience receives €1.8M grant for AMR phage project

2023: A pivotal time for medicine as it enters a new ‘personalized’ era

In Depth 5 Jan 2023

Navignostics maps tumor proteomes to improve precision oncology

Prenetics acquires ACT Genomics

OncoHost to launch PROphet for non-small cell lung cancer in the U.S. in 2023


Entact Bio launches with $81M to develop precision medicines

FogPharma raises $178M to target cancer

NW Bio reports positive top-line results from phase 3 glioblastoma trial

Researchers create mini ‘bone marrow in a dish’ to boost anti-cancer treatments

More News! 9 Nov 2022

PrecisionLife supports Sosei Heptares to treat chronic diseases in more personalized way

Human Immunology Biosciences launches with $120M